CURRENT REPORT UNDER SECTION 17 OF THE SECURITIES REGULATION CODE AND SRC RULE 17.2(c) THEREUNDER
1. Date of Report (Date of earliest event reported)
Dec 4, 2017
2. SEC Identification Number
148022
3. BIR Tax Identification No.
000-288-655-000
4. Exact name of issuer as specified in its charter
Euro-Med Laboratories Phil., Inc.
5. Province, country or other jurisdiction of incorporation
Metro Manila
6. Industry Classification Code(SEC Use Only)
7. Address of principal office
PPL Building, United Nations Avenue cor. San Marcelino St., ManilaPostal Code1007
8. Issuer's telephone number, including area code
00-63-2-5240091 to 98
9. Former name or former address, if changed since last report
N/A
10. Securities registered pursuant to Sections 8 and 12 of the SRC or Sections 4 and 8 of the RSA
Title of Each Class
Number of Shares of Common Stock Outstanding and Amount of Debt Outstanding
common shares
4,112,140,540
11. Indicate the item numbers reported herein
Item 9 : Other Events
The Exchange does not warrant and holds no responsibility for the veracity of the facts and representations contained in all corporate disclosures, including financial reports. All data contained herein are prepared and submitted by the disclosing party to the Exchange, and are disseminated solely for purposes of information. Any questions on the data contained herein should be addressed directly to the Corporate Information Officer of the disclosing party.
Euro-Med Laboratories Phil., Inc.EURO
PSE Disclosure Form 13-1 - Change in Shareholdings of Directors and Principal Officers References: SRC Rule 23 (SEC Form 23-B) and Section 13 of the Revised Disclosure Rules
Subject of the Disclosure
Disposition of EURO Shares
Background/Description of the Disclosure
Please be advised of disposition of EURO shares today, 04 December 2017 by Director/Vice President/Asst. Corporate Secretayr, Michael Vincent Y. Yap.